Proteolytics brings a wound-care solution set to disrupt this multi-billion dollar market through compelling, unique competitive advantages over existing enzymatic agents.

The wound-care sector represents a global market estimated at $24 billion per annum. Currently served by products with limited efficacy, Proteolytics has enormous scope for financial success as well as life-changing advancement for medicine.


Nick Woolf
Chief Executive Officer

PH: +61 417 986 005


Register Your Interest